Takayasu's arteritis treated by percutaneous transluminal angioplasty with stenting in the descending aorta

Byung-Ju Shim1, Ho-Joong Youn, Yong-Chul Kim

  • 1Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Insights

Takayasu

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Vascular Surgery

Background:

  • Takayasu's arteritis is a rare, chronic inflammatory disease affecting large arteries, primarily the aorta and its branches.
  • It predominantly affects young women, leading to stenosis, occlusion, or aneurysms.
  • Early diagnosis and intervention are crucial to prevent severe complications.

Observation:

  • A 17-year-old female presented with a 2-year history of lower extremity claudication and severe arterial hypertension.
  • Physical examination revealed significant blood pressure discrepancies between upper and lower extremities.
  • Elevated inflammatory markers (ESR, CRP) and 3D CT angiography confirmed stenotic changes in the aorta and its branches, consistent with Type IIb Takayasu's arteritis.

Findings:

  • Percutaneous transluminal angioplasty with stenting successfully treated the thoracic and abdominal aorta stenosis.
  • Post-intervention, upper extremity blood pressure normalized, and lower extremity claudication resolved.
  • The patient remained symptom-free with no cardiac events during a 2-year follow-up.

Implications:

  • This case highlights the importance of considering Takayasu's arteritis in young patients with unexplained hypertension and claudication.
  • Endovascular intervention, including angioplasty and stenting, can be an effective treatment for aortic stenosis in Takayasu's arteritis.
  • Successful management can significantly improve quality of life and prevent long-term cardiovascular complications.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...